A Rare Case of Cholestasis: Arthrogryposis, Renal Tubular Disorder and Cholestasis Syndrome
Journal Title: The Journal of Pediatric Research - Year 2018, Vol 5, Issue 3
Abstract
Arthrogryposis, renal tubular dysfunction and cholestasis (ARC) syndrome is a rare, autosomal recessive multisystem disorder. Severe growth retardation, ichthyosis, recurrent febrile disease, platelet abnormalities, sensorineural hearing loss, hypotonia and corpus callosum dysgenesis were later included as further features of this syndrome. We present a case of ARC syndrome diagnosed by genetic analysis.
Authors and Affiliations
Yelda Türkmenoğlu, Yeşim Acar, Fatih Cemal Özdemir, Ralfi Singer, Afig Berdeli, Servet Erdal Adal
Keywords
Related Articles
- EP ID EP382413
- DOI 10.4274/jpr.38257
- Views 85
- Downloads 0
Can Temporomandibular Joint Disorders Be Diagnosed Beforehand by Assessment of Postural Irregularities?
Aim: In many studies, the relationship between postural status and temporomandibular disorders (TMD) have been investigated, however there is no consensus on this regard. The aim of this study was to investigate the rela...
Sleep Characteristics of Pediatric Burn Patients
Aim: Soft tissue injuries which happen because of high heat, chemicals etc. are called burns. Sleep is a complex behavior regulated by the interaction of anatomical and neurochemical areas in the central nervous system....
Bannayan-Riley-Ruvalcaba Syndrome in a Case Evaluated Due to Multinodular Goiter
Bannayan-Rıley-Ruvalcaba syndrome (BRRS) is characterized by macrocephaly, pigmented macules on the glans penis and benign mesodermal hamartomas. 9.6-year-old boy was referred to the pediatric surgeon following an observ...
Impact of a Refresher Training on Pediatric Nurses’ Realization of Their Roles and Functions
Aim: To assess the impact of a refresher training provided to pediatric nurses on the realization of their roles and functions in their nursing practices. Materials and Methods: The study was planned as a single-group re...
Results of Vincristine, Cyclophosphamide and Topotecan Protocol in Refractory/Relapsed Pediatric Solid Tumors: A Single-center Experience
Aim: Despite dramatic progress in the treatment of pediatric solid tumors in the last 3 decades, confronting a relapsed or refractory patient is still challenging. We report our experience of refractory/relapsed pediatri...